Financial
FY2025 revenue €22.46bn (+1.7%); operating margin 9.8%; net income €1.60bn.
Net debt rose to €5.31bn after acquisitions.
Capgemini
HQ France · Europe
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
At a glance
Financial health
Band: Fair
Customer rating
No reviews yet
Financial health
Band: FairListed: CAP.PA
FY2025 revenue €22.46bn (+1.7%); operating margin 9.8%; net income €1.60bn.
Net debt rose to €5.31bn after acquisitions.
Source: official results release · Year ended 2025-12-31 · Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
| Year | Revenue | Growth | Operating profit | Net income | Covers |
|---|---|---|---|---|---|
| FY2025 | €22.5bn | +1.7% | €2.2bn | €1.6bn | Capgemini |
Products & services
Products not yet catalogued.
Risk summary
Full risk page with sources →Researched 8 Nov 2026
Adverse media
Feb 2026: Capgemini, an NHS Scotland supplier, decided to sell its US government IT unit after criticism of the unit's work for US immigration enforcement (ICE); in Sep 2026 the sale to ITC Federal was announced. Capgemini said it did not control that unit's classified work.
Cyber & information governance
No data breaches, cyber incidents or regulator action involving Capgemini found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Regulatory & clinical safety
IT services and cloud supplier; no regulatory or clinical safety actions found in the last 24 months.
Contract performance
Jun 2026: Capgemini announced a multi-year contract as lead partner, with NiCE and Route 101, to modernise HMRC's customer contact centre operations on a UK sovereign cloud; the value was not disclosed by the company.
Competitors
No competitors linked yet.